|1||Active, not recruiting||
Phase II Safety and Efficacy Study of F-DOPA PET/CT in Children With Hyperinsulinemic Hypoglycemia
Fluorodopa F 18 in Congenital Hyperinsulinism
|3||Active, not recruiting||
Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism
† Study has passed its completion date and status has not been verified in more than two years.